Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
11.72
-0.23 (-1.92%)
At close: May 16, 2025, 4:00 PM
11.80
+0.08 (0.68%)
After-hours: May 16, 2025, 7:51 PM EDT
Mesoblast Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Mesoblast stock ranges from a low of $12 to a high of $24. The average analyst price target of $18 forecasts a 53.58% increase in the stock price over the next year.
Price Target: $18.00 (+53.58%)
Analyst Consensus: Buy
* Price targets were last updated on Feb 7, 2025.
Analyst Ratings
The average analyst rating for Mesoblast stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Buy Reiterates $15 → $24 | Buy | Reiterates | $15 → $24 | +104.78% | Feb 7, 2025 |
Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 23, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $11 → $15 | Buy | Maintains | $11 → $15 | +27.99% | Dec 19, 2024 |
Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $12 | Hold → Strong Buy | Upgrades | $12 | +2.39% | Sep 24, 2024 |
Jefferies | Jefferies | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Aug 29, 2024 |
Financial Forecast
Revenue This Year
16.41M
from 5.90M
Increased by 178.09%
Revenue Next Year
66.48M
from 16.41M
Increased by 305.06%
EPS This Year
-0.40
from -0.09
EPS Next Year
-0.22
from -0.40
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 20.2M | 82.5M | 350.2M | ||
Avg | 16.4M | 66.5M | 243.2M | ||
Low | 12.7M | 56.8M | 100.9M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 241.6% | 402.8% | 426.7% | ||
Avg | 178.1% | 305.1% | 265.9% | ||
Low | 115.9% | 246.3% | 51.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | -0.07 | -0.05 | 0.14 | |
Avg | -0.40 | -0.22 | 0.01 | |
Low | -0.72 | -0.38 | -0.19 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | - | - | - | |
Avg | - | - | - | |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.